Trial intelligence / Profile preview

Telaprevir-associated antiviral T-cell reconstitution study in chronic hepatitis C

2012-004138-41Phase 3Terminated

Sponsor
Azienda Ospedaliero-Universitaria di Parma
Start
Oct 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of telaprevir, ribavirin and peginterferon alfa-2a in hepatitis C virus infection, sponsored by Azienda Ospedaliero-Universitaria di Parma. Started Oct 2012; status: terminated.

02

Drugs

telaprevirribavirinpeginterferon alfa-2a
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on 2012-004138-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004138-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call